Eric Groen - 22 Mar 2023 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Reporting relationship: General Counsel
Issuer ticker: RANI
Reported as of: 22 Mar 2023
Net transaction value: -$14,863
SEC form: 4
Accepted by SEC: 24 Mar 2023, 16:05:20 UTC
Prior SEC filing: 24 Mar 2022
Next SEC filing: 29 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Eric Groen

Key filing fact

Eric Groen filed Form 4 for Rani Therapeutics Holdings, Inc. (RANI) on 24 Mar 2023.

Key facts

This page summarizes Eric Groen's Form 4 filing for Rani Therapeutics Holdings, Inc. (RANI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Mar 2023, 16:05.

Change

Previous filing in this sequence was filed on 24 Mar 2022.
Current net transaction value: -$14,863.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RANI transaction

Class A Common Stock

Tax liability

Transaction value: $14,863
Shares: -2,498
Change %: -9.4%
Price: $5.95
Shares after: 24,216
Date: 22 Mar 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Groen on March 22, 2022.

Footnote F2

Includes 2,214 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 1, 2022.